New Perspectives in the Studies on Endocannabinoid and Cannabis : Cannabinoid Receptors and Schizophrenia
スポンサーリンク
概要
- 論文の詳細を見る
Cannabis consumption may induce psychotic states in normal individuals, worsen psychotic symptoms of schizophrenic patients, and may facilitate precipitation of schizophrenia in vulnerable individuals. Recent studies provide additional biological and genetic evidence for the cannabinoid hypothesis of schizophrenia. Examinations using [3H]CP-55940 or [3H]SR141716A revealed that the density of CB1 receptors, a central type of cannabinoid receptor, is increased in subregions of the prefrontal cortex in schizophrenia. Anandamide, an endogenous cannabinoid, is also increased in the CSF in schizophrenia. A genetic study revealed that the CNR1 gene, which encodes CB1 receptors, is associated with schizophrenia, especially the hebephrenic type. Individuals with a 9-repeat allele of an AAT-repeat polymorphism of the gene may have a 2.3-fold higher susceptibility to schizophrenia. Recent findings consistently indicate that hyperactivity of the central cannabinoid system is involved in the pathogenesis of schizophrenia or the neural mechanisms of negative symptoms.
- 社団法人 日本薬理学会の論文
- 2004-12-01
著者
-
Ujike Hiroshi
Department Of Neuropsychiatry Okayama University Graduate School Of Medicine And Dentistry
-
MORITA Yukitaka
Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry
-
Morita Yukitaka
Department Of Neuropsychiatry Okayama University Graduate School Of Medicine And Dentistry
関連論文
- Lewy body variant of Alzheimer's disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem
- New Perspectives in the Studies on Endocannabinoid and Cannabis : Cannabinoid Receptors and Schizophrenia
- JGIDA (Japanese Genetics Initiative for Drug Abuse) study for methamphetamine dependence and psychosis
- A Case of Adult-onset Adrenoleukodystrophy with Frontal Lobe Dysfunction: A Novel Point Mutation in the ABCD1 Gene
- An association study between the dymeclin gene and schizophrenia in the Japanese population
- A two-stage case-control association study of PADI2 with schizophrenia
- Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia
- Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population